Free Trial
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel Free VYCO Stock Alerts
OTCMKTS:VYCO

Vycor Medical (VYCO) Stock Price, News & Analysis

$0.07 0.00 (-0.30%)
As of 10/9/2026
Compare

About Vycor Medical Stock (OTCMKTS:VYCO)

View Price History Chart DataSkip Price History Chart
Advanced
1 Day 5 Days 30 Days 90 Days 1 Year
Advanced

Key Stats

Today's Range
$0.07
▼
$0.07
50-Day Range
$0.05
▼
$0.07
52-Week Range
$0.03
▼
$0.20
Volume
N/A
Average Volume
0 shs
Market Capitalization
$2.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Vycor Medical, Inc. is a medical-device company focused on developing products for neurosurgical procedures. Its primary product is the ViewSite Brain Access System, a transparent tubular retractor designed to provide surgeons with access to intracranial surgical sites while helping preserve visibility of surrounding tissue.

The ViewSite system is intended for use in minimally invasive neurosurgery and may support procedures involving the removal of tumors, blood clots and other abnormalities. The company has also developed related visualization and access technologies, including products designed to work with neuroendoscopic equipment.

Vycor Medical markets its products to hospitals, neurosurgeons and other healthcare providers. Publicly available information about the company’s current leadership, geographic operations and broader product portfolio is limited.

AI Generated. May Contain Errors.

Receive VYCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vycor Medical and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VYCO Stock News Headlines

Vycor Medical, Inc. (OTCMKTS:VYCO) Sees Large Decrease in Short Interest
October 1, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31072001
Vycor Medical Releases Financial Results for the Three Months Ended March 31, 2026
June 14, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/TheNewswire.com/1963818/vycor-medical-releases-financial-results-for-the-three-months-ended-march-31-2026/
No. 1 stock to cash in on the death of iPhone
Analyst Josh Baylin, who warned Congress about smartphones years before the iPhone launched, says the world's richest man may be building an iPhone rival he calls Starphone. Baylin points to FCC rulings, two trademarks filed the same day, multibillion-dollar spectrum deals, chip partnerships, and a string of posts from Elon Musk as evidence pointing to one conclusion. See the full research and the stock Baylin is watching now.tc pixel
October 10 at 1:00 AM  |  Stansberry Research (Ad)
EQS-News: Vycor Medical, Inc.: Vycor Medical Releases Financial Results for the Three Months Ended March 31, 2026
May 16, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-05/68512704-eqs-news-vycor-medical-inc-vycor-medical-releases-financial-results-for-the-three-months-ended-march-31-2026-023.htm
Vycor Medical Releases Financial Results for the Year Ended December 31, 2025
March 31, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/vycor-medical-releases-financial-results-185314037.html
New Study on NovaVision's NeuroEyeCoach Shows Significant Benefits for Patients in Home or Clinic Setting
July 8, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/study-novavisions-neuroeyecoach-shows-significant-123000350.html
VYCO Vycor Medical, Inc.
May 31, 2025  |  seekingalpha.comhttps://seekingalpha.com/symbol/VYCO
Vycor Medical Joins B2i Digital Venture Company Program to Build and Educate Its Investor Base
March 14, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/vycor-medical-joins-b2i-digital-161352247.html
See More Headlines

VYCO Stock Analysis - Frequently Asked Questions

Vycor Medical's stock was trading at $0.1210 at the start of the year. Since then, VYCO stock has decreased by 44.6% and is now trading at $0.0670.

Vycor Medical, Inc. (OTCMKTS:VYCO) released its earnings results on Thursday, May, 15th. The medical device company reported ($0.01) EPS for the quarter. The medical device company had revenue of $0.44 million for the quarter.

Shares of VYCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vycor Medical investors own include ACADIA Pharmaceuticals (ACAD), Canopy Growth (CGC), CorMedix (CRMD) and Drone Aviation (DRNE).

Company Calendar

Last Earnings
5/15/2025
Today
10/10/2026
Fiscal Year End
12/31/2026
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Healthcare
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
OTCMKTS:VYCO
Previous Symbol
OTCMKTS:VYCO
CIK
1424768
Web
www.vycormedical.com
Phone
(561) 558-2000
Fax
631-794-2444
Employees
6
Year Founded
2005

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$70 thousand
Net Margins
-3.30%
Pretax Margin
-3.12%
Return on Equity
N/A
Return on Assets
-4.70%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.13
Quick Ratio
0.09

Sales & Book Value

Annual Sales
$1.86 million
Price / Sales
1.20
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.12) per share
Price / Book
-0.56

Miscellaneous

Outstanding Shares
33,420,000
Free Float
31,074,000
Market Cap
$2.24 million
Optionable
Not Optionable
Beta
-0.54

Social Links

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover
7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (OTCMKTS:VYCO) was last updated on 10/10/2026 by MarketBeat.com Staff.
From Our Partners
This free guide explains options the way they should be taught
Most options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...
Base Camp Trading | Sponsoredtc pixel
A weekly dividend fund holding Nvidia and Palantir
CrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...
Investors Alley | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
The only 5 stocks that matter
SpaceX's IPO reportedly minted 4,400 new millionaires, and OpenAI is said to be eyeing a 1 trillion dollar IPO...
TradeSmith | Sponsoredtc pixel
Tech expert smashes iPhone with golf club
Twenty years ago, Josh Baylin told Congress the iPhone was coming, three years before it launched. A $1,500 be...
Stansberry Research | Sponsoredtc pixel
Elon’s Hiding a Potential $20 Trillion Monster Inside Tesla
Elon Musk says there is a product inside Tesla's factories he calls the biggest ever made, ten times bigger th...
StocksToTrade | Sponsoredtc pixel
Banking Nightmare
During the 2008 financial crisis, 485 US banks failed. Martin D. Weiss called 484 of them, a 99.8% accuracy ra...
Weiss Ratings | Sponsoredtc pixel
The 14-Word Loophole That Could Keep Trump in Power Until 2033
A former U.S. Presidential Advisor claims there is a clear path to the presidency in 2028, built around a 14-w...
Paradigm Press | Sponsoredtc pixel